trans-resveratrol-4'-O-beta-D-glucopyranoside: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5322089 |
| CHEMBL ID | 478753 |
| MeSH ID | M000599446 |
| Synonym |
|---|
| 38963-95-0 |
| BIDD:ER0104 |
| resveratrol (3,4',5-trihydroxystilbene) |
| b-d-glucopyranoside, 4-[(e)-2-(3,5-dihydroxyphenyl)ethenyl]phenyl |
| (2s,3r,4s,5s,6r)-2-[4-[(e)-2-(3,5-dihydroxyphenyl)vinyl]phenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol |
| gob c |
| CHEMBL478753 |
| (2s,3r,4s,5s,6r)-2-[4-[(e)-2-(3,5-dihydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| DTXSID60415792 |
| trans-resveratrol 4'-o-beta-d-glucuronide |
| resveratroloside |
| trans-resveratrol-4'-o-beta-d-glucopyranoside |
| bdbm50478491 |
| HY-N4195 |
| Q17089265 |
| CS-0032390 |
| (2s,3r,4s,5s,6r)-2-(4-((e)-3,5-dihydroxystyryl)phenoxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol |
| MS-26498 |
| trans-resveratrol 4'-o-b-d-glucopyranoside |
| 3,4,5-trihydroxystilbene 4-mono-.beta.-d-glycopyranoside |
| resveratrol 4-o-.beta.-d-glucopyranoside |
| 4-((1e)-2-(3,5-dihydroxyphenyl)ethenyl)phenyl .beta.-d-glucopyranoside |
| 4-[2-(3,5-dihydroxyphenyl)ethenyl]phenyl beta-d-glucopyranoside |
| .beta.-d-glucopyranoside, 4-(2-(3,5-dihydroxyphenyl)ethenyl)phenyl, (e)- |
| 50450-48-1 |
| .beta.-d-glucopyranoside, 4-((1e)-2-(3,5-dihydroxyphenyl)ethenyl)phenyl |
| beta-d-glucopyranoside, 4-(2-(3,5-dihydroxyphenyl)ethenyl)phenyl, (e)- |
| 7dbs6rkm2s , |
| resveratrol 4-o-beta-d-glucopyranoside |
| 4-((1e)-2-(3,5-dihydroxyphenyl)ethenyl)phenyl beta-d-glucopyranoside |
| beta-d-glucopyranoside, 4-((1e)-2-(3,5-dihydroxyphenyl)ethenyl)phenyl |
| 4-(2-(3,5-dihydroxyphenyl)ethenyl)phenyl beta-d-glucopyranoside |
| unii-7dbs6rkm2s |
| 3,4,5-trihydroxystilbene 4-mono-beta-d-glycopyranoside |
| AKOS040760670 |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 (µMol) | 19.0000 | 0.0340 | 3.9871 | 10.0000 | AID1519079 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1519071 | Cytotoxicity against C57BL/6 mouse B16F10 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay relative to control | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID336034 | Inhibition of bovine thymus p56LCK | 1993 | Journal of natural products, Oct, Volume: 56, Issue:10 | Kinase inhibitors from Polygonum cuspidatum. |
| AID610400 | Antiinflammatory activity in human CCD-18Co cells assessed as inhibition of IL1beta-induced PGE2 production at 2.5 to 25 uM after 18 hrs | 2010 | Journal of medicinal chemistry, Oct-28, Volume: 53, Issue:20 | Preventive oral treatment with resveratrol pro-prodrugs drastically reduce colon inflammation in rodents. |
| AID1519079 | Inhibition of mushroom tyrosinase using L-dopa as substrate preincubated for 10 mins followed by substrate addition and measured for 5 mins by photometric analysis | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID1519070 | Antimelanogenic activity against C57BL/6 mouse B16F10 cells at 50 uM incubated for 72 hrs relative to control | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID1519074 | Stability of compound in IMDM cell medium incubated for 24 hrs by HPLC analysis | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID336035 | Inhibition of rat brain PKC | 1993 | Journal of natural products, Oct, Volume: 56, Issue:10 | Kinase inhibitors from Polygonum cuspidatum. |
| AID1519078 | Ratio of IC50 for arbutin to IC50 for test compound for inhibition of mushroom tyrosinase | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID1519072 | Drug degradation in IMDM cell medium incubated for 24 hrs by HPLC analysis | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID482994 | Inhibition of amyloid beta 25-35 fibril formation at 10 uM by using UV-visible measurements and electron microscopy analysis | 2010 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11 | New stilbene dimers against amyloid fibril formation. |
| AID1519069 | Antimelanogenic activity against C57BL/6 mouse B16F10 cells at 10 uM incubated for 72 hrs relative to control | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID1519073 | Stability of compound in DMSO at 10 mM incubated for 24 hrs by HPLC analysis | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID1519068 | Antimelanogenic activity against C57BL/6 mouse B16F10 cells incubated for 10 to 50 uM incubated for 24 hrs | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| AID1519077 | Antimelanogenic activity against C57BL/6 mouse B16F10 cells incubated for 72 hrs | 2019 | European journal of medicinal chemistry, Dec-15, Volume: 184 | From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.79) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||